Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nico Derichs

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Journal of Clinical Medicine|July 2, 2020
Activated L-Arginine/Nitric Oxide Pathway in Pediatric Cystic Fibrosis and Its Association with Pancreatic Insufficiency, Liver Involvement and Nourishment: An Overview and New ResultsFolke Brinkmann, Beatrice Hanusch, Manfred Ballmann, et al.
Bioconjugate Chemistry|November 1, 2011
Functional fluorescently labeled bithiazole ΔF508-CFTR corrector imaged in whole body slices in miceHolly R Davison, Stephanie Taylor, Chris Drake, et al.
Journal of Clinical Medicine|December 1, 2020
Local and Systemic Alterations of the L-Arginine/Nitric Oxide Pathway in Sputum, Blood, and Urine of Pediatric Cystic Fibrosis Patients and Effects of Antibiotic TreatmentBeatrice Hanusch, Folke Brinkmann, Sebene Mayorandan, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 24, 2019
Nasal potential difference in suspected cystic fibrosis patients with 5T polymorphismBente L Aalbers, Yasmin Yaakov, Nico Derichs, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 12, 2013
Nasal potential difference measurements in diagnosis of cystic fibrosis: an international surveyLutz Naehrlich, Manfred Ballmann, Jane Davies, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 1, 2019
GLPG1837, a CFTR potentiator, in p.Gly551Asp (G551D)-CF patients: An open-label, single-arm, phase 2a study (SAPHIRA1)Jane C Davies, Olivier Van de Steen, Silke van Koningsbruggen-Rietschel, et al.
The Journal of Pediatrics|January 29, 2017
Diagnosis of Cystic Fibrosis: Consensus Guidelines from the Cystic Fibrosis FoundationPhilip M Farrell, Terry B White, Clement L Ren, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|August 22, 2021
Riociguat for the treatment of Phe508del homozygous adults with cystic fibrosisNico Derichs, Jennifer L Taylor-Cousar, Jane C Davies, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Journal of Clinical Medicine|July 2, 2020
Activated L-Arginine/Nitric Oxide Pathway in Pediatric Cystic Fibrosis and Its Association with Pancreatic Insufficiency, Liver Involvement and Nourishment: An Overview and New ResultsFolke Brinkmann, Beatrice Hanusch, Manfred Ballmann, et al.
Bioconjugate Chemistry|November 1, 2011
Functional fluorescently labeled bithiazole ΔF508-CFTR corrector imaged in whole body slices in miceHolly R Davison, Stephanie Taylor, Chris Drake, et al.
Journal of Clinical Medicine|December 1, 2020
Local and Systemic Alterations of the L-Arginine/Nitric Oxide Pathway in Sputum, Blood, and Urine of Pediatric Cystic Fibrosis Patients and Effects of Antibiotic TreatmentBeatrice Hanusch, Folke Brinkmann, Sebene Mayorandan, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 24, 2019
Nasal potential difference in suspected cystic fibrosis patients with 5T polymorphismBente L Aalbers, Yasmin Yaakov, Nico Derichs, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 12, 2013
Nasal potential difference measurements in diagnosis of cystic fibrosis: an international surveyLutz Naehrlich, Manfred Ballmann, Jane Davies, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 1, 2019
GLPG1837, a CFTR potentiator, in p.Gly551Asp (G551D)-CF patients: An open-label, single-arm, phase 2a study (SAPHIRA1)Jane C Davies, Olivier Van de Steen, Silke van Koningsbruggen-Rietschel, et al.
The Journal of Pediatrics|January 29, 2017
Diagnosis of Cystic Fibrosis: Consensus Guidelines from the Cystic Fibrosis FoundationPhilip M Farrell, Terry B White, Clement L Ren, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|August 22, 2021
Riociguat for the treatment of Phe508del homozygous adults with cystic fibrosisNico Derichs, Jennifer L Taylor-Cousar, Jane C Davies, et al.
Pageof 2